Serial Number | 98860774 |
Word Mark | PL EPA/DHA |
Filing Date | Tuesday, November 19, 2024 |
Status | 641 - NON-FINAL ACTION - MAILED |
Status Date | Wednesday, May 14, 2025 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
Published for Opposition Date | NOT AVAILABLE |
Description of Mark | The mark consists of The letters PL to the left of a cross design and the letters EPA/DHA to the right of the same cross design, all enclosed inside a rectangular box. |
Goods and Services | Dietary supplements for controlling cholesterol; Dietary and nutritional supplements; Dietary supplements for animals; Dietary food supplements; Dietary supplements; Dietary supplements for humans; Lecithin dietary supplements; Dietary and nutritional preparations |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, November 19, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Aker Biomarine Human Ingredients AS |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Lysaker 1327 NO |
Event Date | Event Description |
Tuesday, November 19, 2024 | NEW APPLICATION ENTERED |
Friday, May 9, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, May 13, 2025 | ASSIGNED TO EXAMINER |
Wednesday, May 14, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, May 14, 2025 | NON-FINAL ACTION E-MAILED |
Wednesday, May 14, 2025 | NON-FINAL ACTION WRITTEN |
Friday, May 9, 2025 | NOTICE OF DESIGN SEARCH CODE E-MAILED |